• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Aug19
Vivos Therapeutics released FY2025 Q2 earnings on August 19 After-Market EST, actual revenue USD 3.82 M (forecast USD 3.365 M), actual EPS USD -0.5516 (forecast USD -0.38)
23:00
Vivos Therapeutics released FY2025 Semi-Annual earnings on August 19 After-Market EST, actual revenue USD 6.835 M, actual EPS USD -1.0038
23:00
Jul1
Vivos Therapeutics' VIDASLEEP Receives CMS PDAC Approval
12:31
Jun26
Vivos Announces Release of OSA Treatment Results in European Pediatric Journal
13:44
Jun20
Vivos Therapeutics Files Initial Beneficial Ownership Statement
21:54
Jun13
Vivos Therapeutics Acquires Nevada Sleep Center
21:03

Schedules & Filings

Schedules
Filings
Nov19
Earning Release(EST)

FY2025 Q3 Earning Release

Aug19
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.82 M, Net Income -5.013 M, EPS -0.5516

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 3.016 M, Net Income -3.864 M, EPS -0.4495

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
WSHP
200.000
+506.06%
+167.000
SGBX
6.070
+78.01%
+2.660
BACCR
0.3900
+77.27%
+0.170
SEMR
11.760
+73.96%
+5.000
PGACR
0.3500
+59.02%
+0.130
NUVB
7.150
+48.96%
+2.350
SSEAR
0.2999
+42.81%
+0.090
HXHX
0.7879
+41.15%
+0.230
CABR
1.090
+39.96%
+0.311
STEC
1.050
+38.82%
+0.294
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy